Main Article Content
Aims: To determine the relaxant activity of various extracts from the stems of Uraria rufa Blume and Caesalpinia sappan L. on rats’ prostate strips in vitro.
Study Design: The relaxant efficacies of ethyl acetate and ethanolic extracts from the stems of U. rufa (UEA and UEOH) and C. sappan (CEA and CEOH) were tested on isolated rats’ prostate tissue pre-contracted by adrenaline.
Place and Duration of Study: Department of Biology, Faculty of Science, Chiang Mai University, between February and September 2018.
Methodology: A prostate strip was isolated, mounted in an organ bath filled with Krebs-Henseleit solution and induced to contract by adrenaline. The contracted strip was then exposed to each extract at 250 µg/mL for 30 minutes. The tension was recorded. Relaxant efficacies of various extracts were determined in prostate strips pre-contracted by adrenaline at 10 µM. All extracts were also determined for their bioactive components and the contents of total phenolics and total flavonoids.
Results: The results showed that all of the extracts, as well as tamsulosin, a synthetic drug, exhibited relaxant effects (P < 0.001) on prostate smooth muscles. The UEA exhibited the most potency in relaxing the prostate smooth muscle with a maximal effect of 72.09 ± 2.15 %. The half-maximal effective concentration (EC50) values of the UEA, CEOH, UEOH and CEA were 140.23 ± 9.74, 226.35 ± 7.16, 235.35 ± 24.96 and 236.24 ± 5.05 µg/ml respectively, while tamsulosin was 86.83 ± 8.96 µg/ml. All extracts contained flavonoids, phenolics, sterols, tannins, phlobatannins, terpenoids, cardiac glycosides, alkaloids and reducing sugars. The highest contents of phenolics and flavonoids were found in CEOH and CEA respectively.
Conclusion: We concluded that the ethyl acetate from the stems of U. rufa was the most potent in relaxing the prostate smooth muscles, and it may be useful to relieve the urological symptoms caused by benign prostatic hyperplasia (BPH).
Lee CL, Kuo HC. Current consensus and controversy on the diagnosis of male lower urinary tract symptoms/benign prostatic hyperplasia. Tzu Chi Med J. 2017;29(1): 6-11.
Oelke M, Giuliano F, Mirone V, Xu L, Cox D, Viktrup L. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, ramdomised, parallel, placebo-controlled clinical trial. Eur Urol. 2012;61(5):917-25.
Gacci M, Andersson KE, Chapple C, Maggi M, Mirone V, Oelke M, et al. Latest evidence on the use of phosphodiesterase type 5 inhibitors for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol. 2016;70(1):124-33.
Camoes J, Coelho A, Castro-Diaz D, Cruz F. Lower Urinary tract symptoms and aging: the impact of chronic bladder ischemia on overactive bladder syndrome. Urol Int. 2015;95(4):373-9.
Montorsi F, Moncada I. Safety and tolerability of treatment for BPH. Eur Urol Suppl. 2006;5(20):1004-1012.
Aggarwal S, Thareja S, Verma A, Bhardwaj TR, Kumar M. An overview on 5α-reductase inhibitors. Steroids. 2010; 75(2):109-53.
Roehrborn CG, Cruz F, Fusco F. α1-blockers in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: Is Silodosin different? Adv Ther. 2016;33(12):2110-2121.
Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5α-reductase inhibitors therapy: Persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med. 2011;8(3):872-84.
Deepralard K, Kawanishi K, Moriyasu M, Pengsuparp T, Suttisri R. Flavonoid glycosides from the leaves of Uvaria rufa with advanced glycation end-products inhibitory activity. Thai J Pharm Sci. 2009; 33(2-3):84-90.
Nguyen TH, Ho VD, Do TT, Bui HT, Phan VK, Sak K. et al. A new lignan glycoside from the aerial parts and cytotoxic investigation of Uvaria rufa. Nat Prod Res. 2015;29(3):247-52.
Aworet SRR, Angone SA, Madingou NK, Mounanga MB, Datte JY. Study of pharmacological properties of the methanolic extract of Dichrostachys cinerea bark (L.) Wight et Arn (Leguminosae) in isolated myometrium from pregnant rats. J Ethnopharmacol. 2015;169(2015):195-9.
Ijaz S, Akhtar N, Khan MS, Hameed A, Irfan M, Arshad MA, et al. Plant derived anticancer agents: A green approach towards skin cancers. Biomed Pharmacother. 2018;103(2018):1643-1651.
Agbodjogbe WKDD, Aïkpe JFA, Ayedoun MA, Assogba FM, Dansou PH, Gbenou JD. Diuretic and natriuretric activities from ten medicinal plants used in south Benin. J Chem Pharm Res. 2015;7(12):1145-1152.
Nirmal NP, Rajput MS, Prasa RGSV, Ahmad M. Brazilin from Caesalpinia sappan heartwood and its pharmacological activities: A review. Asian Pac J Trop Med. 2015;8(6):421-30.
Yovo M, Alitonou GA, Yedomonhan H, Tchobo F, Dedome O, Sessou P, et al. First report on chemical composition and antimicrobial activity of Artabotrys velutinus Scott-Elliot extracts against some clinical strains in Benin. Am J Appl Chem. 2016;4(3):71-76.
Xu HX, Lee SF. The antibacterial principle of Caesalpinia sappan. Phytother Res. 2004;18(8):647-51.
You EJ, Khil LY, Kwak WJ, Won HS, Chae SH, Lee BH, et al. Effects of brazilin on the production of fructose-2,6-bisphosphate in rat hepatocytes. J Ethnopharmacol. 2005; 102(1):53-7.
Washiyama M, Sasaki Y, Hosokawa T, Nagumo S. Anti-inflammatory constituents of Sappan lignan. Biol Pharma Bull. 2009; 32(5):941-4.
Sireeratawong S, Piyabhan P, Singhalak T, Wongkrajang Y, Temsiririrkkul R, Punsrirat J, et al. Toxicity evaluation of sappan wood extract in rats. J Med Assoc Thai. 2010;93(Suppl7): S50-7.
Xie YW, Ming DS, Xu HX, Dong H, But PPH. Vasorelaxing effects of Caesalpinia sappan: involvement of endogenous nitric oxide. Life Sci. 2000;67(15):1913-8.
Hu CM, Kang JJ, Lee CC, Li CH, Liao JW, Cheng YW. Induction of vasorelazation through activation of nitric oxide synthase in endothelial cells by brazilin. Eur J Pharmacol. 2003;468(1): 37-45.
Wiya C, Saenphet K, Saenphet S, Buncharoen, W. In vitro analysis of antispasmodic activity of ethanolic stem extracts of Uvaria rufa Blume and Anomianthus dulcis (Dunal) J. Sinclair on excised rat’s ileum. Comp Clin Path. 2018;27(2):295-299.
Rosandy AR, Din LB, Yaacob WA, Yusoff NI, Sahidin I, Latip J, et al. Isolation and characterization of compounds from the stem bark of Uvaria rufa (Annonaceae). Malaysian J Anal Sci. 2013;17(1):50-58.
Srinivasan R, Selvam GG, Karthik S, Mathivanan K, Baskaran R, Karthikeyan M, et al. In vitro antimicrobial activity of Caesalpinia sappan L. Asain Pac J Trop Biomed. 2012;2(Suppl 1):S136-S139.
Tip-pyang S, Payakarintarungkul K, Sichaem J, Phuwapraisirisan P. Chemical constituents from the roots of Uvaria rufa. Chem Nat Compd. 2011;47(3):475-476.
Paragas EM, Gehle D, Krohn K, Franzblau SG, Macabeo APG. Anti-tubercular flavonol derivatives from Uvaria rufa. Res J Pharm Biol Chem Sci. 2014;5(6):856-859.
Buncharoen W, Saenphet K, Saenphet S, Thitaram C. Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5α-reductase and enhancing antioxidant status. J Ethnopharmacol. 2016;194(2016):483-4.
Li W, Du L, Li M. Alkaloids and flavonoids as α(1)-adrenergic receptor antagonists. Curr Med Chem. 2011;18(32):4923-32.
Zhang N, Qu K, Wang M, Yin Q, Wang W, Xue L, et al. Identification of higenamine as a novel α1 – adrenergic receptor antagonist. Phytother Res. 2019;33(3): 708-717.
Brandli A, Simpson JS, Ventura S. Isoflavones isolated from red clover (Trifolium pretense) inhibit smooth muscle contraction of the isolated rat prostate gland. Phytomedicine. 2010;17(11):895-901.
Chua T, Eise NT, Simpson JS, Ventura S. Pharmacological characterization and chemical fractionation of a liposterolic extract of saw palmetto (Serenoa repens): Effects on rat prostate contractility. J Ethnopharmacol. 2014;152(2):283-91.
Choo SH, Sung HH, Chae MR, Kang SJ, Han DH, Park JK, et al. Effects of Schisandra chinensis extract on the relaxation of isolated human prostate tissue and smooth muscle cell. J Ethnopharmacol. 2014;156(2014):271-6.
Xu Y, Ventura S. Extracts of bark from the traditional Chinese herb Phellodendron amurense inhibit contractility of the isolated rat prostate gland. J Ethnopharmacol. 2010;127(1):196-9.
Edeoga HO, Okwu DE, Mbaebie BO. Phytochemical constituents of some Nigerian medicinal plants. Afr J Biotechnol. 2005;4(7):685-688.
Ayoola GA, Coker HAB, Adesegun SA, Adepoju-Bellol AA, Obaweyal K, Ezennial EC, et al. Phytochemical screening and antioxidant activities of some selected medicinal plants used for malaria therapy in Southwestern Nigeria. Trop J Pharm Res. 2008;7(3):1019-1024.
Wolfe K, Wu X, Liu RH. Antioxidant activity of apple peels. J Agric Food Chem. 2003;51(3):609-14.
Ordonez AAL, Gomez JD, Vattuone MA, Isla MI. Antioxidant activities of Sechium edule (Jacq.) Swart extracts. Food Chem. 2006;97(3):452-458.
Li J, Tian Y, Guo S, Gu H, Yuan Q, Xie X. Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms. PLoS One. 2018;13(1): e0191469.
Park MS, Kim BR, Kang S, Kim DY, Rho SB. The antihypertension drug doxazosin suppresses JAK/STATs phosphorylation and enhances the effects of IFN-α/Ƴ-induced apoptosis. Genes Cancer. 2014; 5(11-12):470-479.
Ko KG, H L, Jin JJ, Kim SH, Han JH, Jeon JW, et al. Add-on therapy with the α-blockers tamsulosin and naftopidil improves voiding function by enhancing neuronal activity in prostatic hyperplasia rats. Int Neurourol J. 2018;22(1):20-29.
Ichihara K, Masumori N, Fukuta F, Tsukamoto T, Iwasawa A, Tanaka Y. A randomized controlled study of the efficacy of tamsulosin monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic obstruction. J Urol. 2015;193(3):921-926.
Sudrania MK, Dangi AD, Kumar S, Kumar B, Kekre NS. Urodynamic outcomes of tamsulosin in the treatment of primary bladder neck obstruction in men. Indian J Urol. 2018;34(1):34-38.
Herrera MD, Marhuenda E, Gibson A. Effects of Genistein, an isoflavone isolated from Genista tridentate, on isolated guinea-pig ileum and guinea-pig ileal myenteric plexus. Planta Med. 1992;58(4): 314-6.
Carreiro JN, Souza ILL, Pereira JC, Vasconcelos LHC, Travassos RA, Santos BVO, et al. Tocolytic action and underlying mechanism of galetin 3,6-dimethyl ether on rat uterus. BMC Complement Altern Med. 2017;17(1):514.
Kline L, Karpinski E. Quercetin relaxes guinea pig gallbladder strips. Nutr Res. 2016;36(10):1098-1104.
Pagano E, Laudato M, Griffo M, Capasso R. Phytotherapy of benign prostatic hyperplasia. A minireview. Phytother Res. 2014;28(7):949-55.
Giuliano F, Ückert S, Maggi M, Birder L, Kissel J, Viktrup L. The mechanism of action of phophodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. Eur Urol. 2013;63(3):506-16.
Cao N, Haynes JM, Ventura S. Saw palmetto is an indirectly acting sympathomimetic in the rat-isolated prostate gland. Prostate. 2006;66(2): 115-23.
Lang RJ, Mulholland E, Exintaris B. Characterization of the ion channel currents in single myocytes of the guinea pig prostate. J Urol. 2004;172(3): 1179-87.